O	0	3	The	The	DT	B-NP
O	4	11	effects	effect	NNS	I-NP
O	12	14	of	of	IN	B-PP
O	15	24	oxidative	oxidative	JJ	B-NP
O	25	31	stress	stress	NN	I-NP
O	32	34	on	on	IN	B-PP
O	35	37	in	in	FW	B-NP
O	38	42	vivo	vivo	FW	I-NP
B-Organ	43	48	brain	brain	NN	I-NP
O	49	52	GSH	GSH	NN	I-NP
O	53	61	turnover	turnover	NN	I-NP
O	62	64	in	in	IN	B-PP
O	65	70	young	young	JJ	B-NP
O	71	74	and	and	CC	I-NP
O	75	81	mature	mature	JJ	I-NP
O	82	86	mice	mouse	NNS	I-NP
O	86	87	.	.	.	O

O	88	99	Glutathione	Glutathione	NN	B-NP
O	100	101	(	(	(	O
O	101	104	GSH	GSH	NN	B-NP
O	104	105	)	)	)	O
O	106	116	synthetase	synthetase	NN	B-NP
O	117	127	activities	activity	NNS	I-NP
O	128	131	and	and	CC	O
O	132	135	GSH	GSH	NN	B-NP
O	136	144	turnover	turnover	NN	I-NP
O	145	150	rates	rate	NNS	I-NP
O	151	155	were	be	VBD	B-VP
O	156	164	examined	examine	VBN	I-VP
O	165	171	during	during	IN	B-PP
O	172	178	severe	severe	JJ	B-NP
O	179	188	oxidative	oxidative	JJ	I-NP
O	189	195	stress	stress	NN	I-NP
O	196	198	in	in	IN	B-PP
O	199	202	the	the	DT	B-NP
O	203	208	mouse	mouse	NN	I-NP
B-Organ	209	214	brain	brain	NN	I-NP
O	215	217	as	as	IN	B-SBAR
O	218	225	induced	induce	VBN	B-VP
O	226	228	by	by	IN	B-PP
O	229	230	t	t	NN	B-NP
O	230	231	-	-	HYPH	O
O	231	249	butylhydroperoxide	butylhydroperoxide	NN	B-NP
O	250	251	(	(	(	O
O	251	252	t	t	NN	B-NP
O	252	253	-	-	HYPH	B-NP
O	253	258	BuOOH	BuOOH	NN	I-NP
O	258	259	)	)	)	O
O	259	260	.	.	.	O

B-Organ	261	266	Brain	Brain	NN	B-NP
O	267	270	GSH	GSH	NN	I-NP
O	271	281	synthetase	synthetase	NN	I-NP
O	282	292	activities	activity	NNS	I-NP
O	293	295	in	in	IN	B-PP
O	296	297	8	8	CD	B-NP
O	297	298	-	-	HYPH	I-NP
O	298	300	mo	mo	AFX	I-NP
O	300	301	-	-	HYPH	I-NP
O	301	304	old	old	JJ	I-NP
O	305	309	mice	mouse	NNS	I-NP
O	310	312	in	in	IN	B-PP
O	313	316	the	the	DT	B-NP
B-Multi-tissue_structure	317	323	cortex	cortex	NN	I-NP
O	323	324	,	,	,	O
B-Multi-tissue_structure	325	333	striatum	striatum	NN	B-NP
O	333	334	,	,	,	O
B-Multi-tissue_structure	335	343	thalamus	thalamus	NN	B-NP
O	343	344	,	,	,	O
B-Multi-tissue_structure	345	356	hippocampus	hippocampus	NN	B-NP
O	356	357	,	,	,	O
B-Multi-tissue_structure	358	366	midbrain	midbrain	NN	B-NP
O	366	367	,	,	,	O
O	368	371	and	and	CC	O
B-Multi-tissue_structure	372	382	cerebellum	cerebellum	NN	B-NP
O	383	387	were	be	VBD	B-VP
O	388	393	found	find	VBN	I-VP
O	394	396	to	to	TO	I-VP
O	397	405	increase	increase	VB	I-VP
O	406	415	following	follow	VBG	B-PP
O	416	417	t	t	NN	B-NP
O	417	418	-	-	HYPH	B-NP
O	418	423	BuOOH	BuOOH	NN	I-NP
O	424	433	treatment	treatment	NN	I-NP
O	433	434	.	.	.	O

O	435	438	The	The	DT	B-NP
O	439	445	effect	effect	NN	I-NP
O	446	448	of	of	IN	B-PP
O	449	452	GSH	GSH	NN	B-NP
O	453	462	synthesis	synthesis	NN	I-NP
O	463	465	on	on	IN	B-PP
B-Organ	466	471	brain	brain	NN	B-NP
O	472	475	GSH	GSH	NN	I-NP
O	476	484	turnover	turnover	NN	I-NP
O	485	490	rates	rate	NNS	I-NP
O	491	494	for	for	IN	B-PP
O	495	496	2	2	CD	B-NP
O	496	497	-	-	HYPH	I-NP
O	498	501	and	and	CC	I-NP
O	502	503	8	8	CD	I-NP
O	503	504	-	-	HYPH	I-NP
O	504	506	mo	mo	AFX	I-NP
O	506	507	-	-	HYPH	I-NP
O	507	510	old	old	JJ	I-NP
O	511	515	mice	mouse	NNS	I-NP
O	516	520	were	be	VBD	B-VP
O	521	531	determined	determine	VBN	I-VP
O	532	537	after	after	IN	B-PP
O	538	561	intracerebroventricular	intracerebroventricular	JJ	B-NP
O	562	563	(	(	(	O
O	563	566	icv	icv	NN	B-NP
O	566	567	)	)	)	O
O	568	577	injection	injection	NN	B-NP
O	578	580	of	of	IN	B-PP
O	581	582	[	[	(	B-NP
O	582	585	35S	35S	NN	I-NP
O	585	586	]	]	)	I-NP
O	586	594	cysteine	cysteine	NN	I-NP
O	594	595	.	.	.	O

O	596	600	Rate	Rate	NN	B-NP
O	601	610	constants	constant	NNS	I-NP
O	611	614	for	for	IN	B-PP
O	615	618	GSH	GSH	NN	B-NP
O	619	627	turnover	turnover	NN	I-NP
O	628	632	were	be	VBD	B-VP
O	633	643	determined	determine	VBN	I-VP
O	644	646	by	by	IN	B-PP
O	647	652	least	least	JJS	B-ADJP
O	652	653	-	-	HYPH	B-NP
O	653	660	squares	square	VBZ	B-VP
O	661	670	iterative	iterative	JJ	B-NP
O	671	683	minimization	minimization	NN	I-NP
O	684	688	from	from	IN	B-PP
O	689	692	the	the	DT	B-NP
O	693	701	specific	specific	JJ	I-NP
O	702	710	activity	activity	NN	I-NP
O	711	715	data	datum	NNS	I-NP
O	716	720	from	from	IN	B-PP
O	721	723	20	20	CD	B-NP
O	724	727	min	min	NN	I-NP
O	728	730	to	to	TO	B-PP
O	731	734	108	108	CD	B-NP
O	735	736	h	h	NN	I-NP
O	737	742	after	after	IN	B-PP
O	743	744	[	[	(	O
O	744	747	35S	35S	NN	O
O	747	748	]	]	)	O
O	748	756	cysteine	cysteine	NN	B-NP
O	757	771	administration	administration	NN	I-NP
O	771	772	.	.	.	O

O	773	776	GSH	GSH	NN	B-NP
O	777	780	and	and	CC	I-NP
O	781	792	glutathione	glutathione	NN	I-NP
O	793	802	disulfide	disulfide	NN	I-NP
O	803	804	(	(	(	O
O	804	808	GSSG	GSSG	NN	B-NP
O	808	809	)	)	)	O
O	810	818	specific	specific	JJ	B-NP
O	819	829	activities	activity	NNS	I-NP
O	830	834	were	be	VBD	B-VP
O	835	845	determined	determine	VBN	I-VP
O	846	851	after	after	IN	B-PP
O	852	862	separation	separation	NN	B-NP
O	863	865	by	by	IN	B-PP
O	866	870	high	high	JJ	B-NP
O	870	871	-	-	HYPH	I-NP
O	871	879	pressure	pressure	NN	I-NP
O	880	886	liquid	liquid	NN	I-NP
O	887	901	chromatography	chromatography	NN	I-NP
O	902	903	(	(	(	O
O	903	907	HPLC	HPLC	NN	B-NP
O	907	908	)	)	)	O
O	908	909	.	.	.	O

O	910	913	The	The	DT	B-NP
O	914	918	half	half	NN	I-NP
O	918	919	-	-	HYPH	I-NP
O	919	923	life	life	NN	I-NP
O	924	926	of	of	IN	B-PP
O	927	930	GSH	GSH	NN	B-NP
O	931	933	in	in	IN	B-PP
O	934	937	the	the	DT	B-NP
O	938	939	2	2	CD	I-NP
O	939	940	-	-	HYPH	I-NP
O	940	942	mo	mo	AFX	I-NP
O	942	943	-	-	HYPH	I-NP
O	943	946	old	old	JJ	I-NP
O	947	952	mouse	mouse	NN	I-NP
O	953	956	was	be	VBD	B-VP
O	957	959	59	59	CD	B-NP
O	959	960	.	.	.	O
O	960	961	5	5	CD	B-NP
O	962	963	h	h	NN	I-NP
O	964	967	and	and	CC	B-PP
O	968	970	in	in	IN	B-PP
O	971	974	the	the	DT	B-NP
O	975	976	8	8	CD	I-NP
O	976	977	-	-	HYPH	I-NP
O	977	979	mo	mo	AFX	I-NP
O	979	980	-	-	HYPH	I-NP
O	980	983	old	old	JJ	I-NP
O	984	989	mouse	mouse	NN	I-NP
O	990	993	was	be	VBD	B-VP
O	994	996	79	79	CD	B-NP
O	996	997	.	.	.	O
O	997	998	1	1	CD	B-NP
O	999	1000	h	h	NN	I-NP
O	1000	1001	.	.	.	O

O	1002	1004	In	In	IN	B-PP
O	1005	1012	summary	summary	NN	B-NP
O	1012	1013	,	,	,	O
O	1014	1021	defense	defense	NN	B-NP
O	1022	1032	mechanisms	mechanism	NNS	I-NP
O	1033	1040	against	against	IN	B-PP
O	1041	1050	oxidative	oxidative	JJ	B-NP
O	1051	1057	stress	stress	NN	I-NP
O	1058	1060	in	in	IN	B-PP
O	1061	1064	the	the	DT	B-NP
B-Organ	1065	1070	brain	brain	NN	I-NP
O	1071	1077	differ	differ	VBP	B-VP
O	1078	1082	with	with	IN	B-PP
O	1083	1086	age	age	NN	B-NP
O	1086	1087	.	.	.	O

O	1088	1093	Young	Young	JJ	B-NP
O	1094	1098	mice	mouse	NNS	I-NP
O	1099	1102	can	can	MD	B-VP
O	1103	1111	increase	increase	VB	I-VP
O	1112	1115	the	the	DT	B-NP
B-Cell	1116	1124	cellular	cellular	JJ	I-NP
O	1125	1137	availability	availability	NN	I-NP
O	1138	1140	of	of	IN	B-PP
O	1141	1144	GSH	GSH	NN	B-NP
O	1144	1145	,	,	,	O
O	1146	1153	whereas	whereas	IN	O
O	1154	1160	mature	mature	JJ	B-NP
O	1161	1165	mice	mouse	NNS	I-NP
O	1166	1169	can	can	MD	B-VP
O	1170	1178	increase	increase	VB	I-VP
O	1179	1182	GSH	GSH	NN	B-NP
O	1183	1193	synthetase	synthetase	NN	I-NP
O	1194	1202	activity	activity	NN	I-NP
O	1203	1209	during	during	IN	B-PP
O	1210	1219	oxidative	oxidative	JJ	B-NP
O	1220	1226	stress	stress	NN	I-NP
O	1226	1227	.	.	.	O

O	1228	1233	These	These	DT	B-NP
O	1234	1245	differences	difference	NNS	I-NP
O	1246	1250	make	make	VBP	B-VP
O	1251	1257	mature	mature	JJ	B-NP
O	1258	1262	mice	mouse	NNS	I-NP
O	1263	1267	more	more	RBR	B-ADJP
O	1268	1279	susceptible	susceptible	JJ	I-ADJP
O	1280	1282	to	to	TO	B-VP
B-Organ	1283	1288	brain	brain	VB	I-VP
O	1289	1298	oxidative	oxidative	JJ	B-NP
O	1299	1305	damage	damage	NN	I-NP
O	1305	1306	.	.	.	O

